Inventor
KLAKAMP SCOTT L
US12 patents
⚠️ This page may combine multiple inventors who share the name “KLAKAMP SCOTT L”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
AMGEN FREMONT INC
6 patentsUS7736644B2Jun 15, 2010
Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
AMGEN FREMONT INC77 citations98
US7628986B2Dec 8, 2009
Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
AMGEN FREMONT INC119 citations98
US7566772B2Jul 28, 2009
Antibodies against interleukin-1β
AMGEN FREMONT INC72 citations96
US7964193B2Jun 21, 2011
Antibodies against interleukin-1 β
AMGEN FREMONT INC29 citations91
US10508153B2Dec 17, 2019
Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
AMGEN FREMONT INC1 citations72
US11492411B2Nov 8, 2022
Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
AMGEN FREMONT INC0 citations61
WEBER RICHARD
5 patentsUS9096672B2Aug 4, 2015
Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
WEBER RICHARD16 citations92
US9062113B2Jun 23, 2015
Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
WEBER RICHARD7 citations83
US9073998B2Jul 7, 2015
Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
WEBER RICHARD3 citations73
US10118968B2Nov 6, 2018
Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
WEBER RICHARD2 citations72
US9085624B2Jul 21, 2015
Antibodies directed to the deletion mutants of epidermal growth factor receptor and uses thereof
WEBER RICHARD2 citations62